These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16247489)

  • 1. Polymorphisms in the prostate-specific antigen gene promoter do not predict serum prostate-specific antigen levels in African-American men.
    Beebe-Dimmer JL; Lange LA; Cain JE; Lewis RC; Ray AM; Sarma AV; Lange EM; Cooney KA
    Prostate Cancer Prostatic Dis; 2006; 9(1):50-5. PubMed ID: 16247489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
    Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
    J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
    Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer.
    Chavan SV; Maitra A; Roy N; Chavan PR
    Indian J Med Res; 2014 Mar; 139(3):371-8. PubMed ID: 24820830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.
    Donin NM; Loeb S; Cooper PR; Roehl KA; Baumann NA; Catalona WJ; Helfand BT
    BJU Int; 2014 Dec; 114(6b):E50-E55. PubMed ID: 24712975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.
    Cramer SD; Sun J; Zheng SL; Xu J; Peehl DM
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2451-7. PubMed ID: 18768516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
    Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
    Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms.
    Rao A; Chang BL; Hawkins G; Hu JJ; Rosser CJ; Hall MC; Meyers DA; Xu J; Cramer SD
    Urology; 2003 Apr; 61(4):864-9. PubMed ID: 12670590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer.
    Tajtakova M; Pidanicova A; Valansky L; Lachvac L; Nagy V; Sivonova M; Dobrota D; Kliment J; Petrovicova J
    Neoplasma; 2010; 57(2):118-22. PubMed ID: 20099974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population.
    Wang LZ; Sato K; Tsuchiya N; Yu JG; Ohyama C; Satoh S; Habuchi T; Ogawa O; Kato T
    Cancer Lett; 2003 Dec; 202(1):53-9. PubMed ID: 14643026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
    Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
    Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels.
    Li W; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Melander O; Ulmert D; Lilja H; Klein RJ
    Prostate; 2020 Dec; 80(16):1405-1412. PubMed ID: 32914890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
    Xu X; Valtonen-André C; Sävblom C; Halldén C; Lilja H; Klein RJ
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2035-42. PubMed ID: 20696662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).
    Sieh W; Edwards KL; Fitzpatrick AL; Srinouanprachanh SL; Farin FM; Monks SA; Kronmal RA; Eaton DL
    Cancer Causes Control; 2006 Mar; 17(2):187-97. PubMed ID: 16425097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
    Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
    Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
    Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
    Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.
    Hoffmann TJ; Passarelli MN; Graff RE; Emami NC; Sakoda LC; Jorgenson E; Habel LA; Shan J; Ranatunga DK; Quesenberry CP; Chao CR; Ghai NR; Aaronson D; Presti J; Nordström T; Wang Z; Berndt SI; Chanock SJ; Mosley JD; Klein RJ; Middha M; Lilja H; Melander O; Kvale MN; Kwok PY; Schaefer C; Risch N; Van Den Eeden SK; Witte JS
    Nat Commun; 2017 Jan; 8():14248. PubMed ID: 28139693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer.
    Yang Q; Shan L; Segawa N; Nakamura M; Nakamura Y; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2001; 21(1A):197-200. PubMed ID: 11299734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.